EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Genital cutaneous candidiasis versus chronic recurrent vulvovaginal candidiasis: distinct diseases, different populations

Tania Day iD, Jack D Sobel iD

Clinical Microbiology Reviews · 12.06.2025 · 38 (2)

DOI: 10.1128/cmr.00020-25 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 12.06.2025. Verfasst von Tania Day und 1 weiteren Autor:innen. Beteiligte Einrichtung: Maternity and Gynaecology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia. Hauptthemen laut MEDLINE: Candidiasis, Vulvovaginal, Candidiasis, Cutaneous. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vulvovaginal candidiasis (VVC) affects over half of women during their lifetime. There are two categorization systems for VVC: uncomplicated versus complicated and acute versus recurrent. Most uncomplicated or acute cases occur in postpubertal premenopausal girls and women as sporadic vaginitis due to Candida albicans . Complicated VVC includes recurrent, chronic, or severe cases, presence of non- albicans species, and/or disease occurring in people with diabetes, immunosuppression, or pregnancy. These classification systems fail to distinguish the two distinct clinical categories of genital candidiasis: estrogen-dependent VVC and estrogen-independent cutaneous candidiasis. These entities are characterized by different pathogenesis, patient demographics, predisposing conditions, symptoms, signs, investigations, differential diagnosis, treatment, and ancillary measures. The current international and national guidelines on VVC are inadequate in their description of the clinical presentation, role and limitations of culture, biopsy findings, and management of cutaneous candidiasis. Progress toward improved patient outcomes will require the interdisciplinary collaboration of researchers and guideline authors to separate these two entities, unify terminology for each, explore the roles of medications and comorbid dermatoses, detail pragmatic and accessible diagnostic processes, define treatment goals, and discuss the long-term management strategies pertinent to each condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Candidiasis, VulvovaginalCandidiasis, CutaneousHumansFemaleRecurrenceAntifungal Agents

Stichwörter der Autor:innen

candidal intertrigocandidosiscutaneous candidiasisgenital mycosisvulvavulvovaginal candidiasisyeast

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Maternity and Gynaecology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
  • University of Newcastle School of Medicine and Public Health, Callaghan, New South Wales, Australia.
  • Division of Infectious Diseases, Wayne State University, Detroit, Michigan, USA.

ORCID-Profile: Tania Day, Jack D Sobel

Zitieren

APA

Day, T., & Sobel, J. D. (2025). Genital cutaneous candidiasis versus chronic recurrent vulvovaginal candidiasis: distinct diseases, different populations. Clinical Microbiology Reviews, 38(2). https://doi.org/10.1128/cmr.00020-25

Vancouver

Day T, Sobel JD. Genital cutaneous candidiasis versus chronic recurrent vulvovaginal candidiasis: distinct diseases, different populations. Clinical Microbiology Reviews. 2025;38(2). doi:10.1128/cmr.00020-25

BibTeX
@article{Day2025,
  author = {Day, Tania and Sobel, Jack D},
  title = {Genital cutaneous candidiasis versus chronic recurrent vulvovaginal candidiasis: distinct diseases, different populations},
  journal = {Clinical Microbiology Reviews},
  year = {2025},
  volume = {38},
  number = {2},
  doi = {10.1128/cmr.00020-25}
}
Kostenlos starten →